Gabapentin withdrawal is a real and sometimes serious medical phenomenon that occurs when someone who has been taking gabapentin regularly stops the drug abruptly or tapers too quickly. Symptoms can appear within hours to days and range from anxiety and insomnia to confusion, seizures, and agitation severe enough to require emergency care. Though gabapentin was long considered to have negligible dependence potential, a growing body of case reports and clinical experience paints a different picture, particularly for people on higher doses or those with a history of substance use.
How Gabapentin Affects the Brain and Why That Matters When You Stop
Despite being designed as a structural analog of the brain chemical GABA, gabapentin does not actually work on GABA receptors. Instead, it binds to a specific part of voltage-gated calcium channels called the α2δ-1 subunit.1PubMed Central. Mechanisms of the gabapentinoids and α 2 δ-1 calcium channel subunit in neuropathic pain By attaching to this subunit, gabapentin reduces the release of excitatory neurotransmitters, which is why it helps with nerve pain, anxiety, and certain seizure types.2Pain. Mechanisms of analgesia by gabapentin and pregabalin – Calcium channel α2-δ ligands
When the brain has been exposed to gabapentin for weeks or months, it adjusts to this dampening effect. It compensates by becoming more excitable at baseline. Remove the drug suddenly and the brain’s excitatory signaling rebounds without anything to check it. Researchers have described this as a “glutamate storm,” a surge in the brain’s primary excitatory neurotransmitter that can drive the agitation, confusion, and seizure risk seen in withdrawal.3PubMed Central. The Hidden Dangers of Gabapentinoids in Older Adults: From Accelerated Cognitive Decline to Withdrawal-Induced Neurotoxicity This rebound mechanism is broadly similar to what happens when someone stops alcohol or benzodiazepines abruptly, which is why gabapentin withdrawal symptoms can resemble those conditions.4PubMed. Gabapentin withdrawal syndrome in the presence of a taper
What Gabapentin Withdrawal Feels Like
The symptom profile of gabapentin withdrawal is broad and not always predictable. In one well-documented hospital case, a patient who had her gabapentin stopped during admission developed restlessness, disorientation, confusion, agitation, and anxiety by day three. Over the following two days, these worsened and she began complaining of headache, light sensitivity, and increasing nervousness.5American Journal of Health-System Pharmacy. Withdrawal symptoms after gabapentin discontinuation In another case, a 76-year-old woman who ran out of her gabapentin prescription and went four days without it showed up at the emergency department with agitation, a changed mental state, and involuntary restless movements of her arms and legs. Her symptoms resolved within eight hours once gabapentin was restarted.6PubMed. Akathisia induced by gabapentin withdrawal
Commonly reported withdrawal symptoms include:
- Anxiety and agitation: often the earliest and most prominent complaint, sometimes escalating to panic-like states
- Confusion and disorientation: mental fog that can be mistaken for delirium from other causes, especially in older adults
- Insomnia: difficulty falling or staying asleep, sometimes accompanied by vivid or disturbing dreams
- Physical symptoms: sweating, nausea, headache, chest pain, light sensitivity, and elevated blood pressure
- Restlessness and akathisia: an inner sense of needing to move, with repetitive limb motions that are difficult to control
- Seizures: the most dangerous potential complication, particularly in people who were taking gabapentin for epilepsy but also reported in people using it for pain
The resemblance to alcohol and benzodiazepine withdrawal is not just superficial. The shared mechanism of excitatory rebound means that clinicians who are not aware a patient was taking gabapentin can easily misattribute the symptoms to another condition, especially in hospital settings where medication lists are sometimes incomplete.
Timeline and Onset
Across published case reports, withdrawal symptoms have appeared anywhere from 12 hours to 7 days after discontinuation.7SAGE Journals (The Annals of Pharmacotherapy). Gabapentin: Abuse, Dependence, and Withdrawal For most people, the first signs show up within one to two days. But the window can stretch longer. In one case report, a patient who was being tapered off gabapentin developed mild upper respiratory and somatic symptoms one day after stopping, which then worsened gradually over the next ten days before suddenly escalating into severe mental status changes, chest pain, and high blood pressure.8PubMed. Gabapentin withdrawal syndrome in the presence of a taper
That case is particularly telling because the patient was being tapered, not stopped cold turkey. The delayed, two-phase pattern of withdrawal caught her treatment team off guard. When gabapentin was restarted, she returned to her baseline within one to two days. This rapid resolution after reintroduction is a consistent finding across case reports and serves as a kind of clinical confirmation that the symptoms were indeed withdrawal.
Who Is Most Vulnerable
Not everyone who stops gabapentin will experience withdrawal. Several factors raise the risk considerably.
Dose appears to matter. In a review of 18 case reports involving gabapentin addiction or withdrawal, patients were taking an average of more than 3,000 mg per day, with a range spanning 600 to 8,000 mg daily.9SAGE Journals (The Annals of Pharmacotherapy). Gabapentin: Abuse, Dependence, and Withdrawal Standard therapeutic doses for nerve pain typically run between 900 and 1,800 mg per day, so many of these patients were well above the usual range. That said, withdrawal has been documented at therapeutic doses too, so a high dose is a risk factor rather than a prerequisite.
A history of substance use disorders is the single most consistent risk factor. In that same review, every case of gabapentin addiction occurred in patients who had a previous history of alcohol, cocaine, or opioid misuse.10SAGE Journals (The Annals of Pharmacotherapy). Gabapentin: Abuse, Dependence, and Withdrawal The reason likely relates to how people with a history of dependence respond to any drug that modulates the brain’s reward and inhibitory circuits, even one that is not directly rewarding in the way opioids or benzodiazepines are.
Older adults face a different set of risks. Age-related changes in kidney function slow gabapentin clearance, meaning the drug accumulates to higher effective levels. Chronic use in older adults may also accelerate cognitive decline independently of withdrawal, making the decision to continue or stop more complicated.11PubMed Central. The Hidden Dangers of Gabapentinoids in Older Adults: From Accelerated Cognitive Decline to Withdrawal-Induced Neurotoxicity And when withdrawal does happen in this population, the confusion and agitation can be mistaken for dementia progression or delirium from another cause.
Tapering Off Gabapentin Safely
The standard clinical advice is to taper gabapentin gradually rather than stopping it abruptly. Most prescribing guidelines suggest reducing the dose over at least a week, but that timeline is often far too aggressive for people who have been on high doses for extended periods.
One remarkable case report illustrates just how slow a taper sometimes needs to be. A patient with alcohol use disorder who had been on high-dose gabapentin experienced intolerable withdrawal symptoms after accidentally missing doses. Using a structured approach, her clinicians reduced her daily dose by about 100 mg per month at first. Once she reached 300 mg per day, the reductions slowed to 20 to 30 mg per month. For the final stretch below 100 mg, the dose was trimmed by just 5 mg every one to two weeks. The entire process took 18 months.12PubMed. Gabapentin dependence and withdrawal requiring an 18-month taper in a patient with alcohol use disorder: a case report
That case is extreme, and most people will not need anything close to an 18-month taper. But it highlights two important points. First, the rate of reduction that someone can tolerate varies enormously from person to person. Second, the final portion of the taper is often the hardest. Even small absolute reductions represent a larger percentage drop when you are already at a low dose, which is why some patients do well through most of the taper and then hit a wall near the end.
There is no universally agreed-upon tapering schedule, and the evidence base consists almost entirely of case reports rather than controlled trials. If you are coming off gabapentin and experiencing symptoms, the most practical step is to slow the taper down and communicate with your prescriber. Reintroduction at the previous tolerable dose and then resuming a slower taper is a common and reasonable strategy.
The Opioid Connection
Gabapentin’s relationship with opioid use complicates the withdrawal picture. The drug is sometimes prescribed alongside opioids for pain management, and it has also become commonly used off-label to help manage opioid withdrawal symptoms. But gabapentin is also widely diverted and misused by people with opioid use disorders. In a study of people seeking inpatient opioid detoxification, those who were obtaining gabapentin without a prescription reported using it to get high, increase the effects of heroin, substitute for opioids, or self-treat opioid withdrawal.13PubMed Central. Prescribed and non-prescribed gabapentin use among persons seeking inpatient opioid detoxification
Overusing gabapentin alongside opioids raises the stakes substantially. A large retrospective analysis of commercially insured patients found that sustained overuse of gabapentin alone was associated with increased odds of hospitalization and emergency visits for altered mental status. When gabapentin and opioids were both being overused, the odds of hospitalization roughly quadrupled, and the risk of respiratory depression climbed sharply as well.14PubMed. All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications For someone in this situation, withdrawal from gabapentin may overlap with opioid withdrawal or with the effects of continued opioid use, creating a clinical picture that is difficult to untangle.
How Gabapentin Compares to Pregabalin
Pregabalin, marketed as Lyrica, works through the same calcium channel mechanism as gabapentin. The two are sometimes treated as interchangeable in clinical practice, but they are not identical when it comes to dependence and withdrawal. A systematic review found that pregabalin appeared to be somewhat more addictive than gabapentin, with greater behavioral dependence symptoms, a higher rate of patients transitioning from prescribed use to self-administration, and more durable patterns of misuse.15PubMed. How addictive are gabapentin and pregabalin? A systematic review
Pregabalin’s faster absorption and more predictable blood levels probably explain why it produces a more noticeable subjective effect and, therefore, a stronger dependence signal. For practical purposes, this means that switching from gabapentin to pregabalin in the hope of an easier discontinuation is not a useful strategy. If anything, the withdrawal risk with pregabalin is higher. Prescribing trends in the UK show that pregabalin use climbed dramatically between 2004 and 2019, with rates of new prescriptions nearly quintupling over that period.16The Lancet Regional Health – Europe. Trends in gabapentinoid prescribing in UK primary care using the Clinical Practice Research Datalink: an observational study Almost a fifth of gabapentinoid prescriptions in that dataset were linked to pain conditions for which the drugs are not formally licensed, suggesting that the growing dependence problem is partly driven by expanding off-label use.
Withdrawal in Newborns
Gabapentin crosses the placenta, which means infants born to mothers taking gabapentin during pregnancy can experience withdrawal after delivery. The symptoms in newborns look different from those in adults. In a case series of 19 infants whose mothers had been taking both opioids and gabapentin, 15 displayed a distinctive pattern of tongue thrusting, wandering eye movements while awake, back arching, and continuous extremity movements. These symptoms did not fit the typical profile of neonatal opioid withdrawal. Ten of the infants could not be weaned off methadone treatment alone, and when gabapentin was added to their treatment, all ten developed the same distinctive movement pattern, further confirming that the behaviors were related to gabapentin.17The Journal of Pediatrics. An Atypical Withdrawal Syndrome in Neonates Prenatally Exposed to Gabapentin and Opioids
Standalone neonatal gabapentin withdrawal has also been reported in the absence of opioid co-exposure.18PubMed. Neonatal Gabapentin Withdrawal Syndrome The clinical challenge is recognition. Neonatal withdrawal scoring tools were designed primarily around opioid withdrawal symptoms like high-pitched crying and tremor. The gabapentin-specific signs of tongue thrusting and wandering eye movements may not trigger these scoring systems, meaning affected infants can go unrecognized if the clinical team is not specifically looking for gabapentinoid withdrawal.
Regulatory Responses and Scheduling
Gabapentin is not classified as a controlled substance at the federal level in the United States, though several states have moved to change that on their own. The evidence so far suggests those moves can have a measurable impact. When West Virginia classified gabapentin as a Schedule V controlled substance, the state saw an immediate drop in gabapentin-involved fatal overdoses compared to neighboring North Carolina, which had not made the same change.19PubMed Central. Impact of schedule V controlled substance classification of gabapentin on adult gabapentin-involved overdose rates, West Virginia, 2016-2019
Schedule V is the lowest tier of controlled substances, meaning the prescribing restrictions are relatively modest. Prescriptions require monitoring through prescription drug monitoring programs, and refills require more active prescriber involvement. Whether scheduling reduces the frequency of physical dependence and withdrawal in therapeutic users is a separate question. The West Virginia data primarily captures overdose deaths, which involve a different population than the chronic pain patient who develops withdrawal after years of prescribed use. For that second group, the more relevant intervention is clinical awareness: knowing that gabapentin can produce physical dependence, planning for a gradual taper when discontinuation is appropriate, and recognizing withdrawal symptoms when they appear rather than attributing them to the underlying condition the drug was prescribed for in the first place.
When Withdrawal Gets Mistaken for Something Else
One of the trickiest aspects of gabapentin withdrawal is that it can mimic conditions the patient already has. Someone taking gabapentin for anxiety who suddenly stops may appear to be having a severe anxiety relapse rather than a withdrawal syndrome. Someone taking it for nerve pain may report escalating pain that looks like disease progression. In older adults, the confusion and agitation of gabapentin withdrawal is easily attributed to a urinary tract infection, new-onset delirium, or worsening dementia.
The hospital setting is particularly risky. Gabapentin is frequently left off admission medication reconciliation lists, sometimes because the patient does not think of it as an important medication, sometimes because it is recorded under a brand name the patient does not recognize, and sometimes because it is obtained without a prescription. The akathisia case mentioned earlier is a good example: the patient’s involuntary restless movements and altered mental status were the presenting complaints, and the connection to gabapentin discontinuation was only made once her medication history was carefully reviewed.20PubMed. Akathisia induced by gabapentin withdrawal When gabapentin was restarted, her symptoms resolved within hours. That rapid resolution is the clinical red flag worth remembering: if a patient’s mysterious agitation or confusion clears up within a day of restarting gabapentin, the diagnosis is almost certainly withdrawal.
For anyone currently taking gabapentin who is considering stopping, the evidence strongly favors talking to your prescriber and planning a gradual reduction rather than stopping on your own. Even if you are on a relatively modest dose and have never had issues with substance use, a slow taper costs you very little and avoids a potentially miserable and occasionally dangerous withdrawal experience.